Macrogenics Inc. (MGNX)
NASDAQ · Healthcare
Macrogenics Inc. Shareholder Equity 2011–2025
Macrogenics Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Macrogenics Inc. shareholder equity as of December 31, 2025: 55.6M, a 52.10% decrease year-over-year.
- Macrogenics Inc. shareholder equity for 2025 were 55.6M, a 52.10% decrease from 2024.
- Macrogenics Inc. shareholder equity for 2024 were 116.1M, a 23.95% decrease from 2023.
- Macrogenics Inc. shareholder equity for 2023 were 152.6M, a 7.46% increase from 2022.
- Macrogenics Inc. shareholder equity for 2022 were 142.0M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Macrogenics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $56 |
| 2024 | $116 |
| 2023 | $153 |
| 2022 | $142 |
| 2021 | $240 |
| 2020 | $296 |
| 2019 | $231 |
| 2018 | $243 |
| 2017 | $299 |
| 2016 | $269 |
| 2015 | $313 |
| 2014 | $121 |
| 2013 | $79 |
| 2012 | $-8 |
Macrogenics Inc. Shareholder Equity — FAQ
Macrogenics Inc. (MGNX) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MGNX's shareholder equity history?
The chart and table above show Macrogenics Inc.'s shareholder equity by year and by quarter, including the growth rate.